These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Hepatocyte growth factor and omega-3-enriched feeds have a synergistic effect on mucosal mass in an animal model of inflammatory bowel disease. Katz MS, Thatch KA, Schwartz MZ. J Pediatr Surg; 2012 Jan; 47(1):194-8. PubMed ID: 22244416 [Abstract] [Full Text] [Related]
6. Synergy of glucagon-like peptide-2 and epidermal growth factor coadministration on intestinal adaptation in neonatal piglets with short bowel syndrome. Lim DW, Levesque CL, Vine DF, Muto M, Koepke JR, Nation PN, Wizzard PR, Li J, Bigam DL, Brubaker PL, Turner JM, Wales PW. Am J Physiol Gastrointest Liver Physiol; 2017 Apr 01; 312(4):G390-G404. PubMed ID: 28104586 [Abstract] [Full Text] [Related]
11. Glucagon-like peptide-2 protects impaired intestinal mucosal barriers in obstructive jaundice rats. Chen J, Dong JT, Li XJ, Gu Y, Cheng ZJ, Cai YK. World J Gastroenterol; 2015 Jan 14; 21(2):484-90. PubMed ID: 25593463 [Abstract] [Full Text] [Related]
12. Glucagonlike peptide-2 enhances small intestinal absorptive function and mucosal mass in vivo. Kato Y, Yu D, Schwartz MZ. J Pediatr Surg; 1999 Jan 14; 34(1):18-20; discussion 20-1. PubMed ID: 10022136 [Abstract] [Full Text] [Related]
13. Effects of exogenous glucagon-like peptide-2 and distal bowel resection on intestinal and systemic adaptive responses in rats. Lai SW, de Heuvel E, Wallace LE, Hartmann B, Holst JJ, Brindle ME, Chelikani PK, Sigalet DL. PLoS One; 2017 Jan 14; 12(7):e0181453. PubMed ID: 28738080 [Abstract] [Full Text] [Related]
14. Enhancement of intestinal adaptation by hepatocyte growth factor. Kato Y, Yu D, Schwartz MZ. J Pediatr Surg; 1998 Feb 14; 33(2):235-9. PubMed ID: 9498393 [Abstract] [Full Text] [Related]